Treatment challenges and complications with Ziconotide monotherapy in established pump patients

Pain Physician

Volumn 9, Issue 2, 2006, Pages 147-152

  Thompson, James C ^a   Dunbar, Elmer ^a   Laye, Rashonda R ^a  

^a PSC   (United States)

Author keywords

Adverse events; Psychological distress; Treatment complications; Treatment outcome; Ziconotide

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUPIVACAINE; DIAZEPAM; ESCITALOPRAM; HYDROCODONE; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OMEGA CONOTOXIN MVIIA; SERTRALINE; SUFENTANIL;

ADULT; ANALGESIA; ANXIETY DISORDER; ARTICLE; ASTHENIA; AVOIDANCE BEHAVIOR; BLURRED VISION; CASE REPORT; CASE STUDY; CHRONIC PAIN; COGNITIVE DEFECT; CONFUSION; CONSULTATION; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSESTHESIA; EMOTIONAL STRESS; FEMALE; HUMAN; INFUSION PUMP; INSOMNIA; LEG PAIN; LOW BACK PAIN; MAINTENANCE DRUG DOSE; MALE; MAXIMUM PERMISSIBLE DOSE; MENTAL DISEASE; MONOTHERAPY; NAUSEA; NEUROPATHIC PAIN; PANIC; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

CALCIUM CHANNEL BLOCKERS; CHRONIC DISEASE; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OMEGA-CONOTOXINS; PAIN MEASUREMENT; PAIN, INTRACTABLE; TREATMENT OUTCOME;

EID: 33646582948     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Olivera B, Gray WR, Zeikus R, McIntosh JM, Varga J, Rivier J, de Santos V, Cruz LJ. Peptide neurotoxins from fish-hunting cone snails. Science 1985; 230: 1338-1343.
2. Mathur VS. Ziconotide: a new pharmacological class of drugs for the management of pain. Seminar in Anesthesia 2000; 19: 67-75.
3. Mathur VS, McGuire D, Bowersox SS, Miljanich GP, Luther RR. Neuronal N-type calcium channels: new prospect in pain therapy. Pharmacology News 1998; 5: 25-29
4. Staats PS, Yearwood T, Charapata SG, Presley RW, Wallace MS, Byas-Smith M, Fisher R, Bryce DA, Mangieri EA, Luther RR, Mayo M, McGuire D, Ellis D. Intrathecal Ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. JAMA 2004; 291 (1): 63-70.
5. Chaplan SR. Neuropathic pain: role of voltage-dependent calcium channels. Regional Anesthesia and Pain Medicine 2000; 25 (3): 283-285.
6. Miljanich GP. Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain. Current medical Chemistry 2004; 11:3029-3040.
7. Ziconotide [prescribing information]. San Diego, CA: Elan Pharmaceuticals, Inc. 2004.
8. Penn RD, Paice JA. Adverse effects associated with the intrathecal administration of Ziconotide. Pain 2000; 85: 291-296.
9. Webster LR, Fakata KL. Ziconotide for chronic severe pain. Practical Pain Management 2005; 5 (4):47-56.
10. Manchikanti L, Pampati VS, Fellows B, Beyer C, Damron K, Barnhill R, Burks T. Characteristics of chronic low back pain patients in an interventional pain management setting: A prospective evaluation. Pain Physician 2001; 4:131-142.
11. Manchikanti L, Pampati VS, Fellows B, Beyer C, Damron K, Barnhill R, Burks T. Comparison of psychological status of chronic pain patients with general population. Pain Physician 2002; 5:40-48.
12. Manchikanti L, Pampati V, Damron K, Beyer C, Damron KS, Barnhill R. Evaluation of psychological status in chronic low back pain; Comparison with general population. Pain Physician 2002; 5: 149-155.
13. Prager J, Jacobs M. Evaluation of patients for implantable modalities; Medical and behavioral assessment. Clinical Journal of Pain 2001; 17.206-214.
14. Block, AR. Presurgical Psychological Screening in Chronic Pain Syndromes. A Guide for the Behavioral Health Clinician. Lawrence Erlbaum Associates, Inc., Mahwah, New Jersey: 1966.
15. Turner JA, Jensen MP. Efficacy of cognitive therapy for chronic low back pain. Pain 1993; 52: 169-177.
16. NIH Technology Assessment Panel. Integration of behavioral and relaxation approaches to the treatment of chronic pain and insomnia. JAMA 1996; 27: 313-318.
17. Turk, DC Okifuji A. A cognitive-behavioral approach to pain management. In Wall PD, Melzack R (eds). Textbook of Pain, Fourth Edition. Churchill Livingstone, London, 1999.
18. Morley S, Eccleston C, Williams AC. Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache. Pain 1999; 80: 1-13.
19. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity, and survival. Journal of Clinical Oncolgy 2002; 20 (19):4040-4049.
20. Hassenbusch SJ, Portenoy RK, Cousins M, Buchser E, Deer TR, DuPen SL, Eisenach J, Follett KA, Hildebrand KR, Krames ES, Levy RM, Palmer PP, Rathmell JP, Rauck RL, Staats PS, Stearns L, Willis KD. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery - report of an expert panel. The Journal of Pain Symptom Management 2004; 27 (6): 540-563.
21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. American Psychiatric Association, Washington DC: 2000.
22. Gatchel RJ, Dersh J. Psychological Disorders and Chronic Pain: Are There Cause-and-Effect Relationships? In Turk DC, Gatchel RJ (eds). Psychological Approaches to Pain Management. A Practitioner's Handbook. The Guilford Press, New York, 2002, pp 30-51.
23. Tollison CD, Satterthwaite JR. Chronic benign pain: Diagnosis and behavior management. Journal of Musculoskeletal Medicine 19991; 8:55-66.
24. Sullivan M, Katon W. Somatization: The path between distress and somatic symptoms. American Pain Society Journal 1993; 2:141-149.
25. Gamsa A. The role of psychological factors in chronic pain. I. A half century of study. Pain 1994; 57:5-15.
26. Fishbain DA. Somatization, secondary gain, and chronic pain: Is there a relationship? Current Review of Pain 1998; 6:101-108.
27. Dickens C, Jayson M, Creed F. Psychological correlates of pain behavior in patients with chronic low back pain. Psychosomatics 2002; 43:42-48.
28. Manchikanti L, Fellows B, Singh V, Pampati V. Correlates of non-physiological behavior in patients with chronic low back pain. Pain Physician 2003; 6:159-166.
29. Admundson GJG, Wright KD. Biopsychosocial Approaches to Pain. In Hadjistavropoulos, T. Craig KD (eds). Pain: Psychological Perspectives. Lawrence Erlbaum Associates, Inc., Mahwah, New Jersey: 2004.
30. Sullivan MD, Turk DC. Psychiatric Illness, Depression, and Psychogenic Pain. In Loeser JD, Butler SH, Chapman CR, Turk DC (eds). Bonica's Management of Pain; Third Edition. Lippincott Williams & Wilklins, Philadelphia, 2001, pp 483-500.
31. Spielberger CD. State-Trait Anxiety Inventory (Form Y). Mind Garden, Palo Alto, CA. 1983.
32. Melzack, R, Katz J. The Gate Control Theory: Reaching for the Brain. In Hadjistavropoulos T, Craig KD (eds). Pain Psychological Perspectives. Lawrence Erlbaum Associates, Inc., Mahwah, New Jersey: 2004.
33. Asmundson GJG, Wright KD, Hadjistavropoulos HD. Anxiety sensitivity and disabling chronic health conditions: State of the art and future directions. Scandinavian Journal of Behavior Therapy 2000, 29:100-117.
34. Asmundson GJG. Anxiety sensitivity and chronic pain: Empirical findings, clinical implications, and future directions. In Taylor S (ed). Anxiety sensitivity. Theory, research and treatment of the Fear of Anxiety. Lawrence Erlbaum Associates, Inc., Mahwah, New Jersey: 1999, pp 269-285.
35. Asmundson, GJG, Taylor S. Role of anxiety sensitivity in pain-related fear and avoidance. Journal of Behavioral Medicine 1996; 19; 577-586.